The 20 Best Bladder Cancer Doctors near Belleville, NJ

William Huang is a Urologist in New York, New York. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.

Guido Dalbagni is a Urologist in New York, New York. Dr. Dalbagni is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Dalbagni is currently accepting new patients.

Mitchell Benson is a Urologist in New York, New York. Dr. Benson is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Prostate Cancer, Urothelial Cancer, Prostatectomy, and Cystectomy.

Christopher Barbieri is a Urologist in New York, New York. Dr. Barbieri is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Vasectomy.

Arjun Balar is an Oncologist in New York, New York. Dr. Balar is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Thrombectomy.

Katie Murray is an Oncologist in New York, New York. Dr. Murray has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Ureteroscopy.

James Wysock is a Urologist in New York, New York. Dr. Wysock is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Urachal Cyst, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

David Solit is an Oncologist in New York, New York. Dr. Solit is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Tissue Biopsy, and Nephrectomy. Dr. Solit is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

"Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as ""Best Reviewer"" in 2014 by The Journal of Urology and in 2016 by Cancer.Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.". Dr. Anderson is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Guarionex Decastro is a Urologist in New York, New York. Dr. Decastro is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

Michael Ciccone is a Urologist in Belleville, New Jersey. Dr. Ciccone is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Urethral Stricture, Enlarged Prostate (BPH), Urinary Incontinence, Ureteroscopy, and Reconstructive Urology Surgery.

Adnan Savera is a Pathologist in Montclair, New Jersey. Dr. Savera is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.

Daniel Lowe is a Urologist in Clifton, New Jersey. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Frequent or Urgent Urination, and Ureteroscopy.

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Ravi Munver is a Urologist in Hackensack, New Jersey. Dr. Munver is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Horseshoe Kidney, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Michelle Kim is a Urologist in Hackensack, New Jersey. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Ureteroscopy.

Mutahar Ahmed is a Urologist in Maywood, New Jersey. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Ureterocele, Nephrectomy, and Ureteral Reconstruction.

Thomas Christiano is a Urologist in Maywood, New Jersey. Dr. Christiano is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Horseshoe Kidney, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery.

Gregory Lovallo is an Oncologist in Maywood, New Jersey. Dr. Lovallo is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Obstructive Uropathy, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Nephrectomy, and Reconstructive Urology Surgery.